ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 832

Single Cell Analysis Reveals Heterogeneity of Type I IFN Gene Expression in Developing Autoreactive B Cells

Jennie Hamilton1, PingAr Yang2, Qi Wu3, Bao Luo4, Shanrun Liu5, Jun Li6, Mark Walter7, Eleanor Fish8, Hui-Chen Hsu3 and John D. Mountz9, 1Medicine/Division of Clinical Immunology and Rhematology, University of Alabama at Birmingham, Birmingham, AL, 2Department of Medicine, Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 3Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 4Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 5Biochemistry & Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL, 6Medicine, University of Alabama at Birmingham, Birmingham, AL, 7Microbiology, University of Alabama at Birmingham, Birmingham, AL, 8University Health Network & Department of Immunology, University of Toronto, Toronto General Research Institute, Toronto, ON, Canada, 9University of Alabama at Birmingham, Department of Medicine, Birmingham, AL

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: autoimmunity and interferons, B cell tolerance, Gene Expression, Lupus

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: B Cell Biology and Targets in Autoimmune Disease

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: B cell development involves passage through a formative transitional B cell stage in the spleen. In SLE, self-nucleic acid reactive B cells fail to be deleted at the transitional B cell stage but the factors promoting specific expansion of these autoreactive cells are unknown. Transitional B cells have been shown to exhibit dysregulated type I interferon (IFN) in SLE, and a sub-population of transitional and naïve B cells from SLE patients were recently shown to express high levels of IFNα. The purpose of these studies was to investigate if B cell endogenous type I IFN can act in an autocrine manner to promote survival and development of autoreactive transitional B cells.

Methods: Wild type C57BL/6 (B6), B6-CD45.1, CD45.2 B6-Rag1–/–, and BXD2 were obtained from Jackson Lab. B6-IFNβ-/- mice were provided by Dr. Fish. A 1:1 ratio of bone-marrow cells was used to reconstitution. Type1 interferon-α or IFNβ stimulation or blockade was carried out using validated sources. Single-cell QRT-PCR was carried out using a Fluidigm-BioMark system on FACS-sorted T1 B cells. Hierarchical clustering was carried out using ClustVis.

Results: Examination of all B cells subsets in B6 and BXD2 mouse spleen revealed that transitional stage 1 (T1) B cells expressed high levels of type I IFNα genes and IFNβ in both strains. T1 B cells from BXD2 lupus-prone mice overexpressed IFNβ relative to B6 mice, and intriguingly, T1 B cells expressed IFNβ at levels comparable to pDCs. T1 B cells from both B6 and BXD2 mice also exhibited higher expression of IFNαR1 and expressed CD86 and CD69 upon IFNβ stimulation. TLR7 responses following stimulation with CL264 was highly dependent upon this endogenous IFN-β in T1 B cells, but not in other B cell subpopulations. Single-cell examination of Ifnb-/- vs. Ifnb+/+ T1 B cells revealed heterogeneous expression of IFNβ in WT T1 B cells and distinct gene expression signatures that required endogenous IFNβ. IFNβ-/- T1 B cells exhibited significantly lower expression of CD86, TLR7, and PKR, and type I IFN genes. Single cell analysis of autoimmune BXD2 T1 B cells that overexpressed IFNβ revealed that IFNβ is expressed in early T1 B cell development with subsequent upregulation of TLR7 and IFNαs. Functional analysis of Ifnb+/+ and Ifnb-/- B cells derived from double chimeric mice revealed that IFNβ was required for development of germinal center, autoreactive, and IgG class switched anti-DNA, anti-La and anti-Histone autoAb producing B cells.

Conclusion: Together, these data highlight the role of IFNβ in shaping T1 B cell responses in the mouse spleen, including their survival and responses to TLR7. Notably, they indicate that these effects are mediated through the endogenous expression of IFNβ in T1 B cells. This mechanism suggests that endogenous IFNβ-expressing T1 B cells are initially autonomous and that their expression of IFNβ plays a key role in regulating their responsiveness to external factors, including externally-derived type 1 IFNs and TLR7. In lupus, overexpression of IFNβ in T1 B cells may promote the development of autoreactive mature B cells leading to the generation of polyreactive self-antigen-reactive mature B cells.


Disclosure: J. Hamilton, None; P. Yang, None; Q. Wu, None; B. Luo, None; S. Liu, None; J. Li, None; M. Walter, None; E. Fish, None; H. C. Hsu, None; J. D. Mountz, None.

To cite this abstract in AMA style:

Hamilton J, Yang P, Wu Q, Luo B, Liu S, Li J, Walter M, Fish E, Hsu HC, Mountz JD. Single Cell Analysis Reveals Heterogeneity of Type I IFN Gene Expression in Developing Autoreactive B Cells [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/single-cell-analysis-reveals-heterogeneity-of-type-i-ifn-gene-expression-in-developing-autoreactive-b-cells/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/single-cell-analysis-reveals-heterogeneity-of-type-i-ifn-gene-expression-in-developing-autoreactive-b-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology